SS

Sachin Sharma

Active Director Director DIN 08455987
DIN 08455987 First appointment May 2019 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since May 2019
Shareholding value β€’β€’β€’β€’ Premium profile

About Sachin Sharma

Data last updated:

Sachin Sharma is a Director at Mokcn Pharmaceuticals Private Limited (since 2019) and Director at Gatmark Laboratory Private Limited (since 2019). The companies operate in Chemicals.

DIN 08455987
Primary Designation Director
Industry Chemicals
First Appointment 22 May 2019
Oldest Company Age 8 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director29 May 20192019Active
Gatmark Laboratory Private Limited U24110UR2018PTC009147
Director22 May 20192018Active

Board colleagues of Sachin Sharma

Directorship timeline

Open interactive timeline →
Gatmark Laboratory Private Limited
Mokcn Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sachin Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sachin Sharma

Sachin Sharma currently holds 2 directorships: Mokcn Pharmaceuticals Private Limited (Director, since 29 May 2019); Gatmark Laboratory Private Limited (Director, since 22 May 2019).

Sachin Sharma was first appointed on 22 May 2019 as Director at Gatmark Laboratory Private Limited.

The current boards of Sachin Sharma's companies include Jyoti Sharma (Mokcn Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available